
Journal of Pharmaceutical Sciences p. 1665 - 1667 (1975)
Update date:2022-08-05
Topics:
Okada
Stella
Haslam
Yata
A study of the effects of various storage conditions on the rate and products of degradation of the quinoline methanol antimalarial agent, α [(dibutylamino)methyl] 6,8 dichloro 2 (3,4 dichlorophenyl) 4 quinoline methanol, was undertaken. The degradation was followed by high pressure liquid chromatography and TLC in oxygenated and deoxygenated methanol, ethanol, chloroform, and chloroform heptane mixtures under UV and laboratory fluorescent lighting irradiation, as well as in the absence of light. The kinetics of degradation confirmed the major catalyzing factor to be UV irradiation. The compound was stable in the absence of light and reasonably stable under fluorescent lighting both in the presence and absence of oxygen. The degradation resulted in a major product, 6,8 dichloro 2 (3,4 dichlorophenyl) 4 quinoline carboxaldehyde, whose structure was confirmed by elemental analysis and IR, NMR, and mass spectral data.
website:http://www.NEM.COM.CN
Contact:+86-393-4411771
Address:The west section of shengli Road,Puyang,Henan Province,China
Jiangxi Hessence Chemicals Co., Ltd.
Contact:+86 796 3511924
Address:Chengxi Industrial Park, Jishui County, Jiangxi Province 331600 China.
Shanghai Hongbang Medical Technology CO.,. Ltd
Contact:13671516988 /18917636693
Address:Room1, No67 Building, Yongde Road369, Wujing Town, Minhang Districy, Shanghai CIty, China.
Taizhou Blazer Biomedical Technology Co., Ltd.
Contact:0523-86112008
Address:Gaogang district Chuangye road.
Anhui New Star Pharmaceutical Development Co., Ltd
Contact:013956922763
Address:Floor 3, F9A, F Workshop, No.110 Kexue Road, High-Tech Development Zone, Hefei, Anhui ,China
Doi:10.1007/s00706-018-2227-6
(2018)Doi:10.1021/jo00098a019
(1994)Doi:10.1002/chem.202001990
(2020)Doi:10.1021/acs.joc.9b01505
(2019)Doi:10.1021/jo01106a050
(1958)Doi:10.1021/jo01075a017
(1960)